AstraZeneca

Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
Proteros expands oncology collaboration with AstraZeneca
Pharmaceutical Business Review
Tue, 05/17/22 - 10:25 am
Proteros
oncology
AstraZeneca
epigenetics
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
Pharmaforum
Tue, 05/17/22 - 10:23 am
BenevolentAI
idiopathic pulmonary fibrosis
AstraZeneca
artificial intelligence
drug development
AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial
Pharmaforum
Mon, 05/16/22 - 10:24 am
AstraZeneca
Avillion
clinical trials
calbuterol/budesonide
inhalers
asthma
AZ, Sanofi build case for one-shot RSV antibody
Pharmaforum
Wed, 05/11/22 - 10:31 am
AstraZeneca
Sanofi
RSV
nirsevimab
AstraZeneca, FibroGen can't agree on roxadustat's path forward in chronic kidney disease after FDA rejection
Fierce Pharma
Tue, 05/10/22 - 10:40 am
AstraZeneca
FibroGen
chronic kidney disease
roxadustat
FDA Approves AstraZeneca, Daiichi Sankyo’s ENHERTU in Breast Cancer
Contract Pharma
Thu, 05/5/22 - 10:40 am
AstraZeneca
Daiichi Sankyo
Enhertu
FDA
HER2+ breast cancer
breast cancer
AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer
Pharmaforum
Thu, 05/5/22 - 10:38 am
AstraZeneca
Imfinzi
biliary tract cancer
FDA
priority review
AZ bites back at rivals with new Farxiga data in heart failure
Pharmaforum
Thu, 05/5/22 - 10:16 am
AstraZeneca
Farxiga
heart failure
clinical trials
AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort
Fierce Pharma
Tue, 05/3/22 - 10:47 am
AstraZeneca
patents
legal
Symbicort
Mylan
Kindeva
Ionis, AstraZeneca change a key trial, fueling more questions about a genetic heart disease
BioPharma Dive
Mon, 05/2/22 - 11:03 am
Ionis Pharmaceuticals
AstraZeneca
clinical trials
transthyretin amyloid cardiomyopathy
AstraZeneca plans new R&D hub in Kendall Square
Pharmaforum
Fri, 04/29/22 - 10:49 am
AstraZeneca
R&D
Cambridge MA
Kendall Square
earnings
AstraZeneca's Ultomiris scores its 3rd FDA approval, setting up market clash with argenx
Fierce Pharma
Thu, 04/28/22 - 11:05 am
AstraZeneca
Ultomiris
FDA
myasthenia gravis
AstraZeneca staves off last Tagrisso copycat with settlement—for now
Fierce Pharma
Wed, 04/27/22 - 10:40 pm
AstraZeneca
Tagrisso
patents
legal
Alembic Pharmaceuticals
generics
Late-stage pain pipeline refuses to swell
EP Vantage
Tue, 04/26/22 - 10:29 pm
painkillers
Vertanical
Teva Pharmaceutical
Regeneron
Ampio Pharmaceuticals
Biogen
Eli Lilly
Vertex Pharmaceuticals
AstraZeneca
Acadia Pharmaceuticals
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA
Endpoints
Mon, 04/25/22 - 10:20 am
AstraZeneca
FDA
tremelimumab
liver cancer
priority review
AstraZeneca says no severe virus cases or deaths after taking antibody
Morningstar
Thu, 04/21/22 - 10:51 am
AstraZeneca
Evusheld
COVID-19
antibodies
AstraZeneca Pushes Deeper into CDx Space with New Collaboration
Medical Devices and Diagnostics Industry
Wed, 04/20/22 - 11:09 am
Medtech
diagnostics
CDx
companion diagnostics
prostate cancer
AstraZeneca
Amoy Diagnostics
Outside of big pharma, life remains tough for listed developers
EP Vantage
Wed, 04/20/22 - 10:38 am
pharma stocks
AbbVie
AstraZeneca
BeiGene
BioNTech
Moderna Therapeutics
Pfizer
Roche
FDA starts speedy review of Enhertu in lung cancer
Pharmaforum
Tue, 04/19/22 - 10:54 am
AstraZeneca
Daiichi Sankyo
FDA
non-small cell lung cancer
Enhertu

Pages